US 12,064,255 B2
Respiratory pressure therapy system
Jeffrey Peter Armitstead, Sydney (AU); Mark David Buckley, Sydney (AU); Michael Waclaw Colefax, Sydney (AU); Susan Robyn Lynch, Maitland (AU); Dion Charles Chewe Martin, Sydney (AU); Gregory Robert Peake, Petersham (AU); Dinesh Ramanan, Sydney (AU); Jamie Graeme Wehbeh, Sydney (AU); and Natalie Zotelo, Sydney (AU)
Assigned to ResMed Inc., San Diego, CA (US)
Filed by ResMed Inc., San Diego, CA (US)
Filed on Feb. 16, 2022, as Appl. No. 17/672,808.
Application 17/672,808 is a continuation of application No. 15/520,663, granted, now 11,278,239, previously published as PCT/AU2015/050655, filed on Oct. 23, 2015.
Claims priority of provisional application 62/068,062, filed on Oct. 24, 2014.
Prior Publication US 2022/0257180 A1, Aug. 18, 2022
This patent is subject to a terminal disclaimer.
Int. Cl. A61B 5/00 (2006.01); A61B 5/08 (2006.01); A61M 16/00 (2006.01); A61M 16/10 (2006.01); A61M 16/16 (2006.01); G16H 20/40 (2018.01)
CPC A61B 5/4833 (2013.01) [A61B 5/0004 (2013.01); A61B 5/0022 (2013.01); A61B 5/08 (2013.01); A61M 16/0051 (2013.01); A61M 16/0069 (2014.02); A61M 16/024 (2017.08); A61M 16/107 (2014.02); A61M 16/16 (2013.01); G16H 20/40 (2018.01); A61M 2205/15 (2013.01); A61M 2205/3344 (2013.01); A61M 2205/3553 (2013.01); A61M 2205/3584 (2013.01); A61M 2205/3592 (2013.01); A61M 2205/42 (2013.01); A61M 2205/502 (2013.01); A61M 2205/583 (2013.01); A61M 2230/40 (2013.01); Y02A 90/10 (2018.01)] 23 Claims
OG exemplary drawing
 
1. A respiratory pressure therapy system comprising:
one or more processors configured to access data associated with usage of a respiratory pressure therapy device that delivers a respiratory pressure therapy to a patient in multiple sessions, the one or more processors being further configured to:
determine a therapy quality indicator of a session of the multiple sessions from usage data relating to the session, the therapy quality indicator being a number derived from adding a plurality of contributions, each of which corresponds to a different usage variable for the session in the usage data, wherein the usage variables comprise at least one of usage time of the session, apnea-hypopnea index for the session, average leak flow rate for the session, and number of sub-sessions within the session, and wherein (a) at least one of the plurality of contributions is set to a first maximum contribution based on a corresponding usage variable exceeding a maximum threshold for that usage variable, or (b) at least one of the plurality of contributions is set to a second maximum contribution based on a corresponding usage variable being less than a minimum threshold for that usage variable; and
based on the therapy quality indicator, (a) alter a setting of the respiratory pressure therapy device, (b) change a therapy mode of the respiratory pressure therapy device, or (c) send a message to a computing device associated with the patient, wherein the message prompts the patient to adjust a component of the respiratory pressure therapy system that is associated with delivering the respiratory pressure therapy.